PRGO
Perrigo Co. Plc
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · IE
$15.96
−2.50%Price chart
Sep 24Sep 29Oct 2Oct 7Oct 12Oct 15Oct 20Oct 23
Key dataOct 23, 2026
Open$16.22
From 52W high−27.26%
Volume1.56M
Market cap$2.21B
P/E (TTM)—
P/S (TTM)0.5x
Div yield7.27%
Key dataOct 23, 2026
Open
$16.22
From 52W high
−27.26%
Volume
1.56M
Market cap
$2.21B
ValuationView details →
P/E (Fwd)
6.4x
EV/EBITDA
−4.9x
P/E (TTM)
—
RSI (14)
58.5
MomentumView details →
1D Return
−2.50%
YTD Return
+14.62%
SummaryUpdated Jun 1, 2026
Perrigo Company plc (NYSE:PRGO) is a Dublin-based consumer healthcare company founded in 1887 that has evolved from a small Michigan pharmacy into a global leader in over-the-counter health and wellness products. The company operates as one of the world's largest manufacturers of store-brand consumer healthcare products, serving both retail chains and consumers directly through its own branded products. Perrigo has undergone significant transformation in recent years, divesting its prescription pharmaceuticals business to focus exclusively on consumer self-care products across the Americas and international markets.
Similar companies
Latest newsMore news →
Perrigo announced that it plans to release its third-quarter 2026 financial results on November 4, 2026, and hold a conference call at 8:30 a.m.4d agoThe listed top gainers included Perrigo, up 3.77%; GILEAD SCIENCES, INC., up 3.8%; Kroger, up 3.87%; BRISTOL MYERS SQUIBB CO, up 4.61%; and UNITEDHEALTH GROUP INC, up 4.73%.11d ago